Failure of H2-receptor antagonists to affect serum calcium and immunoreactive parathyroid hormone levels in normal subjects and patients with primary hyperparathyroidism
Pols, H.A.; De Jong, M.J.; Juttmann, J.R.; Lockefeer, J.H.
Netherlands Journal of Medicine 26(6): 149-152
1983
ISSN/ISBN: 0300-2977 PMID: 6310424 Document Number: 219575
Document emailed within 1 workday
Related Documents
Lundgren, E.; Rastad, J.; Ridefelt, P.; Juhlin, C.; Akerström, G.; Ljunghall, S. 1992: Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism Surgery 112(6): 1123-1129Debruyne, F.; Delaere, P.; Vander Poorten, V. 2001: Postoperative course of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism Acta Oto-Rhino-Laryngologica Belgica 55(2): 153-157
Chen, H.J.; Lai, Y.H.; Su, Y.H.; Tsai, J.H. 1985: Study of serum ionized calcium and immunoreactive parathyroid hormone in patients with renal disorders Gaoxiong Yi Xue Ke Xue Za Zhi 1(3): 188-194
Black, H.E.; Capen, C.C.; Arnaud, C.D. 1973: Ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed normal and high calcium diets Laboratory Investigation; A Journal of Technical Methods and Pathology 29(2): 173-185
Darcan, S.ük.; Coker, M.; Aydinok, Y.şi.; Gökşen, D.; Ozok, G. 2003: Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy Turkish Journal of Pediatrics 45(3): 269-272
Brown, E.M.; Gardner, D.G.; Brennan, M.F.; Marx, S.J.; Spiegel, A.M.; Attie, M.F.; Downs, R.W.; Doppman, J.L.; Aurbach, C.D. 1979: Calcium-regulated parathyroid hormone release in primary hyperparathyroidism: studies in vitro with dispersed parathyroid cells American Journal of Medicine 66(6): 923-931
Gardin, J.P.; Patron, P.; Fouqueray, B.; Prigent, A.; Paillard, M. 1988: Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies Mineral and Electrolyte Metabolism 14(4): 221-228
Laurberg, P.; Charles, P.; Hasling, C.; Mosekilde, L.; Nielsen, H.K. 1988: Serum parathyroid hormone (1-84) assessed by immunoradiometric methods can differentiate malignant hypercalcemia and primary hyperparathyroidism Ugeskrift for Laeger 150(48): 2972-2974
Sriussadaporn, S.; Phoojaroenchanachai, M.; Ploybutr, S.; Plengvidhya, N.; Peerapatdit, T.; Nitiyanant, W.; Vannasaeng, S.; Vichayanrat, A. 2007: Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide Journal of the Medical Association of Thailand 90(4): 663-671
Rodriguez, M.; Lorenzo, V.; Felsenfeld, A.J.; Llach, F. 1986: Changes in serum calcium and phosphorus induced by chronic renal failure in the absence of parathyroid hormone Advances in Experimental Medicine and Biology 208: 383-386
Kruse, H.P.; Kuhlencordt, F.; Ringe, J.D.; Vogel, H.; Montz, R.; Koch, G. 1983: Preoperative localization diagnosis of parathyroid adenomas in 72 cases of primary hyperparathyroidism by selective catheterization of neck veins and parathyroid hormone determination Schweizerische Medizinische Wochenschrift 113(17): 636-640
Shimkin, P.M.; Powell, D. 1973: Parathyroid hormone levels in thyroid-vein blood of patients without abnormalities of calcium metabolism Annals of Internal Medicine 78(5): 714-716
Gillquist, J.; Larsson, L.; Lundström, B.; Eneström, S.; Kågedal, B. 1979: Calcium infusion in suspected hyperparathyroidism: changes in parathyroid hormone concentration related to histopathological findings Acta Chirurgica Scandinavica 145(4): 219-225
Emel Şahin; Ayşe Yeşim Göçmen; Saadet Gümüşlü; Sahin, M.; Hüseyin Koçak; Tuncer, M. 2011: Lipid Peroxidation and Parathyroid Hormone Influence the Cytosolic Calcium Levels of Erythrocytes in Peritoneal Dialysis Patients Clinical Laboratory 57(7-8): 551-557
Vestergaard, P.; Nielsen, L.R.; Mosekilde, L. 2006: Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism Ugeskrift for Laeger 168(1): 29-32
Zur Mühlen A von; Hesch, R.D.; Emrich, D.; Creutzfeldt, W. 1970: Effect of synthetic "thyreotropin releasing factor" on the plasma levels of thyreotropic hormone and growth hormone in healthy subjects, in patients with hyperthyreosis and primary hypothyreosis Deutsche Medizinische Wochenschrift 95(52): 2623-2624
Pironi, L.; Malucelli, E.; Guidetti, M.; Lanzoni, E.; Farruggia, G.; Pinna, A.D.; Barbiroli, B.; Iotti, S. 2009: The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure Magnesium Research 22(1): 37-43
Coen, G.; Mazzuoli, G.F.; Guglielmi, G.; D'Erasmo, E.; Scarda, A.; Paziani, N. 1974: Circadian rhythm of urinary calcium-phosphorus excretion in humans. Role of iodinated hormones, parathyroid hormone, calcitonin, vitamin D and blood calcium levels Folia Endocrinologica 27(6): 507-525
Pagliari, B.; Baretta, A.; De Cristofaro, V.; Samà, F.; Cantaluppi, A.; Martis, L.; Imbasciati, E. 1991: Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 11(4): 326-329
Ferrari, C.; Romussi, M.; Benco, R.; Rampini, P.; Mailland, F. 1983: Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions Acta Endocrinologica 103(1): 1-6